NAIROBI - Nigeria could cut the number of polio cases to zero next year and be declared free of the disease in 2018 even though a national eradication campaign has had to contend with an insurgency in the north, Bill Gates told Reuters.
- U.S. health insurers will send out about $330 million in rebates to employers and individuals this summer under President Barack Obama's healthcare law, the U.S. Department of Health and Human Services said on Thursday.
WASHINGTON - An estimated 10.3 million American adults have gained health coverage since Obamacare enrollment began last October, with the biggest gains among young adults and Hispanics, according to a study published on Wednesday.
WASHINGTON - The director of a U.S. government bioterror lab that potentially exposed scores of workers to live anthrax last month has resigned, the U.S. Centers for Disease Control and Prevention said on Wednesday.
SHANGHAI - China's food regulator has visited close to 600 restaurants, businesses and food distributors as it investigates a fast-spreading food safety scare that has dragged in a number of global brands and hit food outlets as far away as Japan.
SEOUL - South Korea has confirmed a case of foot-and-mouth disease at a hog farm, the country's first outbreak in more than three years, the agriculture ministry said in a statement on Thursday.
SAN FRANCISCO - San Francisco city leaders have approved a measure for the November ballot that would place a two-cents-per-ounce municipal tax on sodas and other sugary beverages, hoping to become the first major city to successfully impose such a levy.
SAN FRANCISCO - Federal Trade Commissioner Julie Brill, speaking in Washington on Wednesday, expressed concern about the way apps on smartphones and mobile devices are siphoning sensitive health data, and how some of that information may then be shared with third parties.
MUMBAI - India's Ipca Laboratories Ltd said on Thursday it has voluntarily suspended shipments to the United States from one of its drug ingredient manufacturing plants after the U.S. Food and Drug Administration (FDA) expressed concerns regarding the unit.
- The U.S. Food and Drug Administration said on Wednesday it has approved Gilead Sciences Inc's Zydelig, a drug to treat three types of blood cancer.
Video: Health Reform Watch
A series that looks at all facets of cancer, written by Debra Sherman, a lung cancer patient who succumbed to the disease on April 22, 2014. Debra covered the health beat for Reuters for more than a decade and drew on her knowledge about health, her contacts in the industry and her personal experiences to report this series. Full Article